Cargando…

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery

Detalles Bibliográficos
Autores principales:	Ibrahim, Hany S., Sippl, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362905/ https://www.ncbi.nlm.nih.gov/pubmed/34395393 http://dx.doi.org/10.3389/fchem.2021.740196

Ejemplares similares

PROTACs: A novel strategy for cancer drug discovery and development
por: Han, Xin, et al.
Publicado: (2023)

Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
por: Pei, Haixiang, et al.
Publicado: (2019)

Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
por: Yuan, Minghua, et al.
Publicado: (2021)

Editorial for Special Issue—“Early-Stage Drug Discovery: Advances and Challenges”
por: Sippl, Wolfgang
Publicado: (2023)

An overview of PROTACs: a promising drug discovery paradigm
por: Liu, Zi, et al.
Publicado: (2022)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

PROTAC: targeted drug strategy. Principles and limitations
por: Koroleva, O. A., et al.
Publicado: (2022)

Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021)

PROTAC chemical probes for histone deacetylase enzymes
por: Patel, Urvashi, et al.
Publicado: (2023)

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

E3 ligase ligand optimization of Clinical PROTACs
por: Jiang, Hanrui, et al.
Publicado: (2023)

Challenges in natural product-based drug discovery assisted with in silico-based methods
por: Simoben, Conrad V., et al.
Publicado: (2023)

Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
por: Muddassir, Mohd., et al.
Publicado: (2020)

Editorial: Novel Strategies in Drug Development Against Multifactorial Diseases
por: Esposito, Cinzia, et al.
Publicado: (2022)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
por: Naito, Mikihiko, et al.
Publicado: (2019)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021)

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

The PROTAC technology in drug development
por: Zou, Yutian, et al.
Publicado: (2019)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020)

PROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery
por: Ermondi, Giuseppe, et al.
Publicado: (2021)

PROTACs bearing piperazine-containing linkers: what effect on their protonation state?
por: Desantis, Jenny, et al.
Publicado: (2022)

Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Development of a covalent cereblon-based PROTAC employing a fluorosulfate warhead
por: Nowak, Radosław P., et al.
Publicado: (2023)

Application of PROTAC strategy to TTR-Aβ protein-protein interaction for the development of Alzheimer’s disease drugs
por: Tonali, Nicoló, et al.
Publicado: (2021)

The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
por: Jin, Jinmei, et al.
Publicado: (2020)

Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Designing Soluble PROTACs: Strategies and Preliminary Guidelines
por: García Jiménez, Diego, et al.
Publicado: (2022)

Recent Advances in PROTAC-Based Antiviral Strategies
por: Ahmad, Haleema, et al.
Publicado: (2023)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cfp3ake4ltd4f35bdct1hl4qi